JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M201654200 on March 21, 2002

J. Biol. Chem., Vol. 277, Issue 23, 20862-20868, June 7, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/23/20862    most recent
M201654200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiest, A.
Right arrow Articles by Kenerley, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiest, A.
Right arrow Articles by Kenerley, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Identification of Peptaibols from Trichoderma virens and Cloning of a Peptaibol Synthetase*

Aric WiestDagger , Darlene GrzegorskiDagger , Bi-Wen XuDagger , Christophe Goulard§, Sylvie Rebuffat§, Daniel J. EbboleDagger , Bernard Bodo§, and Charles KenerleyDagger

From the Dagger  Department of Plant Pathology and Microbiology, Texas A&M University, College Station, Texas 77843 and § Laboratoire de Chimie des Substances Naturelles, Muséum National d'Histoire Naturelle, 63, Rue Buffon, 75005 Paris, France

Received for publication, February 18, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The fungus Trichoderma virens is a ubiquitous soil saprophyte that has been applied as a biological control agent to protect plants from fungal pathogens. One mechanism of biocontrol is mycoparasitism, and T. virens produces antifungal compounds to assist in killing its fungal targets. Peptide synthetases produce a wide variety of peptide secondary metabolites in bacteria and fungi. Many of these are known to possess antibiotic activities. Peptaibols form a class of antibiotics known for their high alpha -aminoisobutyric acid content and their synthesis as a mixture of isoforms ranging from 7 to 20 amino acids in length. Here we report preliminary characterization of a 62.8-kb continuous open reading frame encoding a peptaibol synthetase from T. virens. The predicted protein structure consists of 18 peptide synthetase modules with additional modifying domains at the N- and C-termini. T. virens was shown to produce a mixture of peptaibols, with the largest peptides being 18 residues. Mutation of the gene eliminated production of all peptaibol isoforms. Identification of the gene responsible for peptaibol production will facilitate studies of the structure and function of peptaibol antibiotics and their contribution to biocontrol activity.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Peptaibols, a class of linear peptides of fungal origin with 7-20 residues, have three structural characteristics, (i) a high proportion of alpha ,alpha -dialkylated amino acids with an abundance of alpha -aminoisobutyric acid (Aib),1 (ii) an N-acyl terminus, usually acetyl, and (iii) a C-terminal amino alcohol, such as phenylalaninol or leucinol. Peptaibols naturally occur as mixtures of isoforms, and more than 250 sequences are now known (public-1.cryst.bbk.ac.uk/peptaibol/search.html). They are divided into three subclasses, which are (i) the long sequence peptaibols with 18-20 amino acid residues exemplified by alamethicins (1) or trichorzianins (2-4), (ii) the short-sequence peptaibols with 11-16 residues exemplified by harzianins (5-7) or zervamicins (8, 9), and (iii) the lipopeptaibols (10) with 7 or 11 residues, the N terminus of which is acylated by a short fatty acid chain such as octanoic acid instead of acetic acid represented by trichoginA IV. Peptaibols generally exhibit antimicrobial activity against Gram-positive bacteria and fungi (11). Their biological activities are thought to arise from their membrane-modifying properties and their ability to form transmembrane voltage-dependent channels (12, 13). The producing fungi, mainly of the genus Trichoderma and related genera such as Emericellopsis and Gliocladium, have antagonistic activity against fungal phytopathogens, which has led to their use as biocontrol agents. Mycoparasitic strains of Trichoderma produce cell wall-hydrolyzing enzymes in addition to antibiotics. Peptaibols are thought to act on the membrane of the target fungus to inhibit membrane-associated enzymes involved in cell wall synthesis. Indeed, peptaibols have been shown to act synergistically with cell wall-degrading enzymes to inhibit the growth of fungal pathogens (14, 15). Peptaibols may also elicit plant resistance to pathogens. The exogenous application of peptaibols has been shown to trigger a defense response in lima bean and to reduce the susceptibility of tobacco to tobacco mosaic virus (16, 17).

Because of the potential importance of peptaibols in the biological control of plant diseases, we sought to clone the gene(s) responsible for their synthesis. With their unusual amino acid content, we expected peptaibols to be the product of non-ribosomal peptide synthetases (NRPSs). These large multifunctional enzymes assemble compounds from a remarkable range of precursors (including nonproteinogenic amino acids and hydroxy or carboxyl acids), which can be N-methylated, acylated, reduced, or epimerized (18, 19). NRPSs have a modular structure in which each module is a semiautonomous unit that recognizes, activates, and modifies a single residue of the final peptide (20). Each module can be further partitioned into distinct adenylation (A), thiolation (T), and condensation (C) domains, which together represent a minimal repeating unit of NRPSs (21). Analysis of the phenylalanine activation domain of gramicidin synthetase, GrsA, has been used to determine the key residues responsible for A-domain specificity in substrate recognition (22, 23). These have been referred to as signature sequences. It is hoped that a sufficiently large collection of verified signature sequence/amino acid substrate combinations will provide an NRPS "codon" table allowing prediction of amino acid substrates based on the signature sequences in uncharacterized NRPSs.

Using a PCR-based approach, we identified a peptide synthetase of Trichoderma virens. Here we report the cloning of a gene responsible for the production of peptaibols in T. virens. The predicted open reading frame represents the largest known NRPS and contains modules for the incorporation of 18 amino acids as well as the domain we predict is involved in acetylation of the N terminus and reduction of the C terminus of the peptaibol products.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Fermentation-- Conidial suspensions of T. virens strains TV29-8, TVP223, and TVP234 were inoculated into 120 Roux flasks, each containing 170 ml of the sterilized synthetic medium having the composition glucose (0.5%), KH2PO4 (0.08%), KNO3 (0.07%), Ca(H2PO4)2, (0.02%), MgSO4·7H2O (0.05%), MnSO4·5H2O (0.001%), CuSO4·5H2O (0.0005%), FeSO4·7H2O (0.0001%). Each flask was inoculated with a 2 ml of conidial suspension, and the stationary cultures were incubated at 27 °C for 18 days.

Isolation of Peptaibols-- The fermentation broth was filtered, and the filtrate was extracted 3 times with n-butyl alcohol, whereas the mycelium was extracted 3 times with methanol, yielding 0.9 and 1.1 g of crude fraction, respectively. These two fractions were subjected to gel filtration over a Sephadex LH 20 column eluted with MeOH to yield crude peptide mixtures in the head fractions. We recovered 512 mg of crude peptide mixtures from the culture filtrate fraction and 12 mg from the mycelial fraction of TV29-8. These peptide mixtures were each chromatographed over a silica gel column (Kieselgel 60 H Merck) by elution with a CH2Cl2:MeOH gradient (from 9:1 to 1:1). Each fraction yielded two groups of peptides, TVA and TVB. The culture filtrate yielded 273 mg of TVA and 120 mg of TVB. Lower amounts of TVA (14 mg) and TVB (19 mg) were obtained from the mycelium. The peptides from the mycelium were not analyzed further.

Column chromatographs were monitored by TLC (SiO2, Merck 60 F254; CH2Cl2:MeOH, 7:3) and visualized by spraying with anisaldehyde reagent (p-anisaldehyde:sulfuric acid:acetic acid, 1:1:50) followed by heating. HPLC was performed with a semi-preparative C18 column (Kromasil, 5 µm, 4.6 × 250 mm) with MeOH:H2O, 86:14 as the system eluent (flow rate, 1 ml/min) to separate peptaibol subfractions.

Amino Acid Analysis-- The peptides (1 mg) were hydrolyzed (HCl 6 N, 110 °C, N2), and the amino acids and amino alcohols were derivatized to produce N-trifluoroacetylisopropyl ester derivatives as previously described (2, 3, 6). The gas-liquid chromatography analyses of the N-trifluoroacetylisopropyl esters were performed with a Girdel 3000 chromatograph on a Chirasil-L-Val (N-propionyl-L-valine tert-butylamide polysiloxane) quartz capillary column (Chrompack, 25-m length, 0.2-mm internal diameter) with He (0.7 bar) as the carrier gas with the following temperature program: 50 to 130 °C, 3 °C min-1 followed by 130 to 190 °C, 10 °C min-1. The separation factors (Rt) were (alpha L/D for the L and D enantiomers): Aib, 10.4; L-Ala, 14.8 (1.16); L-Glu, 33.2 (1.05); Gly, 17.8; L-Leu, 24.2 (1.11); L-Ser, 23.0 (1.05); L-Val, 17.7 (1.08); L-Valol, 18 (0.98). A different temperature program was used for the separation of proline enantiomers: 50 to 110 °C, 3 °C min-1, then a plateau at 110 °C (10 min), followed by 110 to 190 °C, 10 °C min-1; Rt (alpha L/D): L-Pro, 25.1 (1.02).

LSI Mass Spectrometry-- Positive LSIMS were recorded on a ZAB2-SEQ (VG Analytical, Manchester, UK) mass spectrometer equipped with a standard fast atom bombardment source and a cesium ion gun operating at 35 kV. Peptide methanolic solutions (15-50 mM) were mixed with alpha -monothioglycerol as a matrix.

NMR Spectroscopy-- Methanolic (CD3OH) solutions of the TVB peptides (0.5 ml, 15 mM) in 5-mm tubes were used for the NMR experiments, which were recorded at 298 K on a Bruker AC 300 equipped with an Aspect 300 computer using DISNMR software. Proton chemical shifts were referenced to the central component of the quintet due to the CHD3 of methanol at 3.313 ppm downfield from tetramethylsilane.

Gliotoxin Test-- Growth conditions, gliotoxin extraction conditions, thin layer chromatography, and detection of gliotoxin were performed as described (24).

DNA Manipulations-- PCR primers Acv2 (TTCCTRTCCAAYTACGTSTTYGAYTTCTC) and Acv5 (GGSACCATRTAYGIKGGAAG) (where Y = C/T, R = A/G, S = C/G, K = G/T, I = inosine) were designed to amplify a portion of the A domain from NRPSs (22). A single PCR product was obtained and used to probe a cosmid library of T. virens.2 One cosmid, 40B7, had high sequence similarity to known peptide synthetases. A probe derived from cosmid 40B7 was used to identify a BAC clone, pDXG70, that was used for further analysis (25).

BamHI fragments of 6.8 and 8.3 kb from cosmid 40B7 were subcloned and sequenced entirely on both strands (Gene Technology Laboratory, Texas A&M). Additional sequences were obtained by direct sequencing from cosmid 40B7 and subclones of bacterial artificial chromosome clone pDXG70. These latter sequences were primarily determined using custom sequencing primers that provided coverage on a single strand. Manual adjustment of the sequences was performed to maintain the reading frame. A vector for gene replacement, pPSK2, was constructed containing 4476- and 2944-bp fragments from cosmid 40B7 that flank the selectable hph (hygromycin phosphotransferase) gene. This plasmid was transformed into TV29-8 as previously described (26) with selection for resistance to hygromycin B. DNA was extracted from 324 transformants as described (27). The 324 transformants were screened by Southern blot analysis to identify strains containing the disruption.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Peptaibol Isolation-- Two crude peptaibol fractions (TVA and TVB) from T. virens strain TV29-8 were obtained by extraction from culture filtrates, exclusion chromatography, and silica gel chromatography ("Experimental Procedures"). When analyzed by reverse phase HPLC, the two peptide groups appeared as complex mixtures of isoforms. Six main peaks were observed for the TVB group. The TVB mixture was submitted to semi-preparative HPLC to yield TVB I to VI (Fig. 1A). Further spectral analysis showed TVB I, II, and IV to be homogeneous, whereas TVB III, V, and VI remained mixtures. The 1H NMR spectra of TVB I, II, and IV were characteristic of peptaibols, showing amide protons between 6.50 and 8.70 ppm, a high proportion of them being singlets, typical of alpha ,alpha -dialkylated amino acids. Several methyl singlets of Aib between 1.30 and 1.60 ppm and a sharp singlet at 2.05 ppm were assigned to the N-terminal acetyl. The TVA fraction was much more complex, and no pure compound was isolated (Fig. 1B).


View larger version (29K):
[in this window]
[in a new window]
 
Fig. 1.   HPLC chromatogram of peptaibols from T. virens. A, TVB peptaibols (Kromasil C18; 5 µm, 1.6 × 250 mm; MeOH/H20 (86:14), flow rate 1 ml/min, absorption monitored at 220 nm). B, peptaibol mixture TVA (Kromasil C8; 5 µm, 1.6 × 250 mm; MeOH/H20 (86:14), flow rate 1 ml/min, absorption monitored at 220 nm). C, sequence of the 18 residue trichorzins TVB I, II, and IV. Variant residues are indicated in bold.

Sequences of Trichorzins TVB I, II, and IV-- The amino acid composition of TVBI was Aib [7] L-Ala [2], Gly [1], L-Gln [2], L-Leu [2], L-Pro [1], L-Ser [1], L-Val [1], and the amino alcohol was L-valinol. Peptide TVB II had an additional L-leucine and no valine, and TVB IV differed from TVB II by the replacement of one Aib by a D-isovaline. When analyzed by (+) liquid secondary ion mass spectrometry, the adduct ions [M+H]+ and [M+Na]+ were observed, allowing the molecular mass to be determined. As generally described for these peptides (7), fragmentation events leading to acylium ions were detected and, thus, allowed the sequences of TVB I, II, and IV to be determined (Fig. 1C).

The [M+Na]+ ion of TVB I was observed at m/z 1727 (Table I). A main fragmentation at the Aib-Pro amide bond led to the b12 acylium ion, which generated a series of acylium fragments at m/z 1009 (b11), 896 (b10), 809 (b9), 724 (b8), 653 (b7), 568 (b6), 440 (b5), 355 (b4), 256 (b3), 185 (b2), 128 (b1), leading to the sequence Ac-Aib-Gly-Ala-Val-Aib-Gln-Aib-Ala-Aib-Ser-Leu-Aib. An ammonium ion was observed at m/z 612 (y6), which underwent fragmentation, leading to a series of acylium ions at m/z 509, 381, 296, and 211 from which the C-terminal sequence Pro-Leu-Aib-Aib-Gln-Valol was deduced (Table I). From their sequence analogy with the 18-residue trichorzin peptaibols (28-30), the name trichorzins TVB is proposed for this group (Table II).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Liquid secondary ion mass spectrometry fragmentation of TVB I, II, and IV

                              
View this table:
[in this window]
[in a new window]
 
Table II
Examples of similar peptaibols produced by T. virens, T. harzianum, and T. koningii
U, alpha -aminoisobutyric acid; J, isovaline.

Similarly, the mass spectrum of TVB II and TVB IV depicted the sodium adduct ions at m/z 1741 and 1755, respectively. The y6 ion was observed at m/z 612 for the two compounds, and it underwent the same fragmentation, suggesting the 13-18-residue C-terminal sequence to be the same as TVB I, Pro-Leu Aib-Aib-Gln-Valol. The b12 acylium ion was at m/z 1108 for TVB II, and its further acylium fragmentation allowed the sequence Ac-Aib-Gly-Ala-Leu-Aib-Gln-Aib-Ala-Aib-Ser-Leu-Aib to be determined for the 1-12-residue N-terminal moiety. This differs from TVBI by the Val/Leu substitution at position 4. The b12 acylium ion for TVB IV was observed at m/z 1122, yielding acylium fragments giving the sequence Ac-Aib-Gly-Ala-Leu-Aib-Gln-D-Iva-Ala-Aib-Ser-Leu-Aib (Fig. 1C).

Mass spectral analysis of TVB  III and V showed they were micro-heterogeneous. The main component of TVB III had the same quasi-molecular ions and fragmentation as TVB II and, therefore, may be an isoform. The pattern for TVB V was most similar to that of TVB IV. Because no pure peptide was obtained from the TVA group, the mixture was analyzed by (+) liquid secondary ion mass spectrometry. Two quasi-molecular [M+Na]+ ions were observed in the high mass region. The more abundant class contained ions at m/z 1183, 1197, 1211, and 1227, suggesting a mixture of 11-residue peptides similar to harzianins HB (5) (Table II). The less abundant class contained ions at m/z 1452, 1466, and 1480, suggesting a mixture of 14-residue peptides similar to harzianins HC (6) (Table II).

Cloning of a Peptide Synthetase from T. virens-- Degenerate primers ("Experimental Procedures") successfully amplified a single PCR product of 886 bp, and subsequent sequence analysis of this product revealed clear homology to known peptide synthetases. The PCR product was used as a probe to identify a cosmid clone, 40B7, of T. virens genomic DNA. Two adjacent BamHI fragments of 6.8 and 8.3 kb (Fig. 2B) were sequenced and revealed a continuous 15.1-kb open reading frame with homology to 4 complete and two partial peptide synthetase modules. Sequence analysis of an additional 3.9-kb region in the 5' direction of the gene revealed that the single open reading frame continued to the end of the cosmid insert. A T. virens bacterial artificial chromosome library was constructed to facilitate cloning of the peptide synthetase (25). A bacterial artificial chromosome clone, pDXG70, was identified through Southern hybridization that contains the entire coding sequence for the gene, called texas-1 (tex1). From the sequences obtained from subclones of pDXG70, we deduce that the gene encodes a single open reading frame of 18 complete peptide synthetase modules and additional domain homologies at the N and C termini of the predicted protein (Fig. 2A). An additional 4.5 kb of sequence downstream of tex1 was determined. Within this region, two sequence homologies were identified; one displayed strong homology to a retrograde regulation protein of Saccharomyces cerevisiae (Rtg2p) and the other to a calcium/proton exchanger of Neurospora crassa. The sequence displaying Rtg2p homology (35% identity) is convergent to tex1 beginning 2.2 kb from the 3' end of tex1 and ending 0.7 kb from tex1. The calcium/proton exchanger homolog (29% identity) is in the same orientation as tex1, beginning 3.25 kb from the end of tex1 and extending to the end of the cosmid insert.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 2.   Modular structure of tex1 and schematic of four modules. A, modular organization of tex1 as revealed by DART (domain architecture search). Modules of the tex1 peptide synthetase are indicated by numbers 1-18. The domains within the modules are indicated. A domain with homology to a portion of ketoacyl synthase domains (pfam00109) and acyltransferase domains (pfam00698) is found at the N terminus. At the C terminus is a motif with similarity to 3 beta -hydroxysteroid dehydrogenase/isomerase family (pfam01073). Assignment of the amino acids to the module is indicated (code: Ac, acetyl group attached to the N-terminal amino acid of the peptide; U, Aib; J, isovaline; V-OH, valinol). Scale represents amino acid position in tex1. B, the 6.8- and 8.3-kb BamHI fragments of the high quality sequence are shown. Restriction enzyme sites are indicated (B, BamHI; E, EcoRI; H, HindIII). The location of the 886-bp PCR product is indicated by the solid bar above module 11. The 0.4-kb EcoRI-HindIII fragment (*) that was replaced by the hygromycin phosphotransferase gene to generate a gene disruptant mutant is shown above module 11.

Conserved sequences in peptide synthetase modules are involved in ATP binding and amino acid thioesterification and transfer (31). These conserved domains are present in each of the modules (Fig. 2A). BLAST alignments comparing the complete modules of tex1 to each other showed 35-58% identity over the entire length of the modules. A comparison of the signature sequence residues showed that all modules have the expected aspartate residue at position 235. Aspartate residues are invariant at this position for modules incorporating amino acids, differing only in modules that incorporate carboxylic acids (32). Modules 6 and 17 have identical residues in the remaining 8 positions (Table III). Modules 1, 5, 9, 12, 15, and 16 share identical residues at positions 236, 239, 299, and 322. These modules also have aromatic residues at position 278. Modules 3 and 8 have identical residues at position 299, 301, 322, and 330 and similar residues at positions 236, 278, and 331. The comparison of signature sequences of the tex1 modules with the sequences of trichorzins TVB I, II, and IV are consistent with the view that the signature sequences determine amino acid specificity.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Signature sequences of putative amino acid activating domains of texI
J, 2-aminoisobutyric acid; U, isovaline; V-OH, valinol.

Disruption of tex1 Abolishes Peptaibol Production-- We generated mutant alleles of tex1 by replacing a 0.4-kb segment of tex1 with a selectable marker conferring resistance to the antibiotic hygromycin B (Fig. 2B). The replacement vector (pPSK2) contained 4.5- and 2.6-kb segments of the peptide synthetase gene flanking the resistance marker (Fig. 3A). The linearized plasmid was used to transform strain TV29-8 and 324 transformants were tested for stable integration of the resistance gene marker (33). These transformants were screened by Southern blot analysis to verify the disruption at the tex1 locus. Two strains, TVP223 and TVP234, were clearly disrupted for the gene (Fig. 3B). Both of the transformants with the disrupted copy of the tex1 gene contained at least one additional ectopic copy of pPSK2. As predicted, bands in the mutant strains all hybridize to a probe obtained from the hygromycin cassette (data not shown).


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 3.   Schematic of gene replacement strategy. A, restriction maps of relevant region of tex1 and gene disruption vector pPSK2 constructed using the pBluescript vector. B, Southern hybridization of TV29-8, TVP223, and TVP234 genomic digests with the 0.95-kb probe indicated in A. Wild type bands are indicated by arrows. Lane 1, 1-kb ladder; lane 2, EcoRI digest of TV29-8; lane 3, EcoRI digest of TVP223; lane 4, EcoRI digest of TVP234; lane 5, XhoI digest of TV29-8; lane 6, XhoI digest of TVP223; lane 7, XhoI digest of TVP234. B, BamHI; E, EcoRI; H, HindIII; S, SalI; X, XhoI.

The two gene disruption transformants were tested in parallel with TV29-8 for peptaibol production. In contrast to the wild type, TV29-8, no peptaibols were found. Strain TV29-8 produces a second antibiotic, gliotoxin, that is also thought to contribute to mycoparasitic activity. Gliotoxin production was examined in all 324 transformed strains, and all produced wild type levels of gliotoxin. This indicates that disruption of tex1 specifically eliminates peptaibol synthesis and does not cause a general defect in secondary metabolite production.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Here we demonstrate that T. virens, widely recognized as a biocontrol agent, produces peptaibol antibiotics. Several classes of peptaibols are produced by T. virens strain TV29-8 including 18-, 14-, and 11-amino acid residue peptides. The sequences of 3 of the 18 amino acid residue peptaibols, trichorzins TVB I, II, and IV, were determined. We have shown here that a large peptide synthetase (2.3 MDa) is responsible for production of all classes of peptaibols in T. virens. The evidence for this is (i) disruption mutants of tex1 failed to make peptaibols, (ii) domain homologies at both the N and C termini are consistent with the predicted functions necessary for acylation and reduction, respectively, and (iii) the gene sequence indicates that tex1 contains modules for the incorporation of 18 amino acid residues.

The intron-less gene will encode a mature protein of 20,925 residues (~2.3 MDa) encoded by a ~63-kb mRNA. This gene would specify the largest mRNA and the largest continuous coding region known. Given these large sizes (a linear 63-kb mRNA would span 10 µm and exceed the diameter of the cell), it is of interest to understand how such large mRNAs and proteins are processed. For example, it is conceivable that translation of the peptide synthetase could initiate before completion of transcription of the gene.

Because genes for secondary metabolite production are often found to be clustered (34), additional genes required for synthesis or export of a mature peptaibol may be identified by further analysis of the flanking regions. Identification of homologs of a retrograde regulation protein (Rtg2p) and a calcium/proton exchanger downstream of tex1 suggests that a gene cluster for peptaibol production does not extend beyond the 3' end of tex1. Preliminary sequence in a 2-kb region upstream of tex1 has not revealed homology to known proteins.

The A domain of peptide synthetases contains 10 conserved motifs (22) that are present in each of the modules of tex1. Likewise, the known conserved motifs in the T domains and C domains were also identified within each module. Amino acid residues 16-196 of the tex1 protein aligned over 80% of the length of ketoacyl synthase domains (pfam00109), typically found in polyketide synthases, with BLAST E value of 1e-11 (35). Residues 416-703 aligned over 91% of the length of acyltransferase domains (pfam00698) (E value = 2e-43). We propose that these domains are responsible for the acetylation of the peptaibol N terminus in accordance with the colinearity of the domains with that of their products (32). Amino acid residues 20552-20781 aligned over 51% of the length of the 3 beta -hydroxysteroid dehydrogenase/isomerase family (pfam01073) (E value = 3e-6) and aligns over 88% of the length of alcohol dehydrogenase domains (pfam00106) (E value = 0.003). We propose that this domain plays a role in the reductive cleavage of the final amino acid to generate the C-terminal alcohol. Therefore, the mature peptaibol synthetase may contain all of the enzymatic activities necessary to produce peptaibols.

Nine residues in the active site of peptide synthetases have been proposed to play a major role in defining substrate specificity for incorporation of amino acids based on structural data (22). These residues define the signature sequences specifying amino acid incorporation. The signature sequences from the modules of tex1 are unique and do not exactly match the signature sequences found in other characterized NRPSs. Therefore, we could not use the signature sequences to make amino acid substrate assignments for the tex1 modules. However, we noted a very strong pattern in which the signature sequences of the 1st, 9th, 12th, 15th, and 16th modules were very similar (Table III). These may correspond to Aib residues found at positions 1, 9, 12, 15, and 16 of the TVB peptaibols. Modules 6 and 17 have identical residues at all 9 positions, and it is likely that these two modules incorporate the glutamate residues found in positions 6 and 17 in the peptaibols.

Peptaibols are among the largest products known that are synthesized by NRPSs, and a tremendous variety of peptaibol sequences has been found. Indeed, T. virens and other peptaibol-producing organisms take advantage of combinatorial chemistry by producing a complex mixture of peptaibol compounds in culture filtrates. This is likely to be a result of the potential of the module to bind multiple substrates. In certain cases, the complexity can be manipulated by supplementing cultures with a specific amino acid (6). This suggests that the incorporation of amino acids into peptaibols reflects the availability of the cognate substrates rather than the existence of multiple NRPSs, each responsible for production of one member of the mixture. Our finding that a single mutation can eliminate all forms of peptaibols confirms this view.

A recent publication reported the partial cloning and characterization of a peptide synthetase from T. virens with a sequence identical to the 3' terminal 5 kb of tex1 (36). Disruption of this gene (psy1) was reported to cause partial or complete loss of hydroxymate siderophore production. The authors concluded that psy1 encodes an NRPS responsible for hydroxymate siderophore production. We believe this to be in error for the following reasons. First, the full sequence of the tex1 (psy1) gene indicates that it synthesizes an 18-amino acid peptide. This is far larger than expected for an enzyme producing hydroxymate-containing siderophores. Second, Neurospora and Aspergillus species are also known producers of hydroxymate siderophores. The genome sequences of N. crassa and Aspergillus fumigatus are now available, and based on BLAST searches, neither genome contains a NRPS with 18 modules or strong sequence similarity to tex1 (psy1). In addition, preliminary growth experiments with our tex1 gene disruption strains did not reveal significant growth defects or deficiency in siderophore production on iron-deficient medium relative to the growth on iron-sufficient medium (37). Although unlikely, it is possible that certain alleles of tex1 affect siderophore production directly or indirectly.

Here we report that peptaibols are produced by a peptide synthetase and the first characterization of a peptaibol synthetase gene. Cloning of additional peptaibol synthetases will facilitate generation of novel peptaibols by precisely replacing modules or making specific changes in the signature sequences. Manipulation of the abundance or sequence of peptaibols and heterologous expression of the T. virens peptaibol synthetase in other biocontrol fungi may prove to be useful tools in enhancing biocontrol activity.

    FOOTNOTES

* This work was supported by Texas Agricultural Experiment Grant 111215 and USDA-NRICGP Grant 99-35316-790.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 979-845-8261; Fax: 979-845-6483; E-mail: kenerley@ppserver.tamu.edu.

Published, JBC Papers in Press, March 21, 2002, DOI 10.1074/jbc.M201654200

2 C. M. Kenerley, unpublished information.

    ABBREVIATIONS

The abbreviations used are: Aib, alpha -aminoisobutyric acid; NRPS, non-ribosomal peptide synthetase; HPLC, high performance liquid chromatography; A, adenylation; C, condensation; T, thiolation; Valol, amino alcohol of valine; Iva, isovaline.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Pandey, R. C., Cook, J. C., Jr., and Rinehart, K. L., Jr. (1977) J. Am. Chem. Soc. 99, 8469-8483
2. Bodo, B., Rebuffat, S., El, Hajji, M., and Davoust, D. (1985) J. Am. Chem. Soc. 107, 6011-6017[CrossRef]
3. El Hajji, M., Rebuffat, S., Lecommandeur, D., and Bodo, B. (1987) Int. J. Peptide Protein Res. 29, 207-215
4. Rebuffat, S., El, Hajji, M., Hennig, P., Davoust, D., and Bodo, B. (1989) Int. J. Pept. Protein Res. 34, 200-210[Medline] [Order article via Infotrieve]
5. Augeven-Bour, I., Rebuffat, S., Auvin, C., Goulard, C., Prigent, Y., and Bodo, B. (1997) J. Chem. Soc. Perkin Trans. I 1587-1594
6. Rebuffat, S., Goulard, C., and Bodo B. (1995) J. Chem. Soc. Perkin Trans. I 1849-1855
7. Rebuffat, S., Hlimi, S., Prigent, Y., Goulard, C., and Bodo B. (1996) J. Chem. Soc. Perkin Trans. I 2021-2027
8. Rinehart, K. L., Jr., Gaudioso, L. A., Moore, M. L., Pandey, R. C., and Cook, J. C., Jr. (1981) J. Am. Chem. Soc. 103, 6517-6520[CrossRef]
9. Karle, I. L., Flippen-Anderson, J. L., Agarwalla, S., and Balaram, P. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 5307-5311[Abstract/Free Full Text]
10. Auvin-Guette, C., Rebuffat, S., Prigent, Y., and Bodo, B. (1992) J. Am. Chem. Soc. 114, 2170-2174[CrossRef]
11. Jen, W.-C., Jones, G. A., Brewer, D., Parkinson, V. O., and Taylor, A. (1987) J. Appl. Bacteriol. 63, 293-298[Medline] [Order article via Infotrieve]
12. Sansom, M. S. P. (1991) Prog. Biophys. Mol. Biol. 55, 139-236[CrossRef][Medline] [Order article via Infotrieve]
13. Rebuffat, S., Duclohier, H., Auvin-Guette, C., Molle, G., Spach, G., and Bodo, B. (1992) FEMS Immunol. Microbiol. 105, 151-160
14. Lorito, M., Woo, S. L., D'Ambrosio, M., Harman, G. E., Hayes, C. K., Kubicek, C. P., and Scala, F. (1996) Mol. Plant-Microbe Interact. 9, 206-213
15. Lorito, M., Farkas, V., Rebuffat, S., Bodo, B., and Kubicek, C. P. (1996) J. Bacteriol. 178, 6382-6385[Abstract/Free Full Text]
16. Engelberth, J., Koch, T., Kühnemann, F., and Boland, W. (2000) Agnew Chem. Int. Ed. Engl. 39, 1860-1862
17. Yun, B., Yoo, I., Kim, Y., Kim, Y., Lee, S., Kim, K., and Yeo, W. (2000) Tetrahedron Lett. 41, 1429-1431[CrossRef]
18. Marahiel, M. A., Stachelhaus, T., and Mootz, H. D. (1997) Chem. Rev. 97, 2651-2673[CrossRef][Medline] [Order article via Infotrieve]
19. Zocher, R., and Keller, U. (1997) Adv. Microb. Physiol. 38, 85-131[Medline] [Order article via Infotrieve]
20. Marahiel, M. A. (1997) Chem. Biol. (Lond.) 4, 561-567[CrossRef][Medline] [Order article via Infotrieve]
21. Stein, T., Vater, J., Kruft, V., Otto, A., Wittmann-Liebold, B., Franke, P., Panico, M., McDowell, R., and Morris, H. R. (1996) J. Biol. Chem. 271, 15428-15435[Abstract/Free Full Text]
22. Stachelhaus, T., Mootz, H., and Marahiel, M. A. (1999) Chem. Biol. (Lond.) 6, 493-505[CrossRef][Medline] [Order article via Infotrieve]
23. Challis, G. L., Ravel, J., and Townsend, C. A. (2000) Chem. Biol. (Lond.) 7, 211-224[CrossRef][Medline] [Order article via Infotrieve]
24. Howell, C. R., Stipanovic, R. D., and Lumsden, L. D. (1993) Biocontrol. Sci. Technol. 3, 435-441
25. Grzegorski, D. (2001) The Construction and Characterization of Three Genomic Libraries of Trichoderma virens Strain Tv29-8.M.Sc. thesis , Texas A&M University
26. Thomas, M. D., and Kenerley, C. M. (1989) Curr. Genet. 15, 415-420[CrossRef]
27. Xu, B., Wild, J. R., and Kenerley, C. M. (1996) J. Ferment. Bioeng. 81, 473-481[CrossRef]
28. Goulard, C., Hlimi, S., Rebuffat, S., and Bodo, B. (1995) J. Antibiot. (Tokyo) 48, 1248-1253[Medline] [Order article via Infotrieve]
29. Hlimi, S., Rebuffat, S., Goulard, C., Duchamp, S., and Bodo, B. (1995) J. Antibiot. (Tokyo) 48, 1254-1261[Medline] [Order article via Infotrieve]
30. Duval, D., Riddell, F. G., Rebuffat, S., Platzer, N., and Bodo, B. (1998) Biochim. Biophys. Acta 17, 370-378
31. Konz, D., and Marahiel, M. A. (1999) Chem. Biol. (Lond.) 6, 39-48
32. Weber, T., and Marahiel, M. A. (2001) Structure (Lond.) 9, 3-9
33. Baek, J. M., and Kenerley, C. M. (1998) Fungal Genet. Biol. 23, 33-44
34. Keller, N. P., and Hohn, T. M. (1997) Fungal Genet. Biol. 21, 17-29[CrossRef][Medline] [Order article via Infotrieve]
35. Altschul, S. F., Gish, W., Miller, W., Myers, E. W., and Lipman, D. J. (1990) J. Mol. Biol. 215, 403-410[CrossRef][Medline] [Order article via Infotrieve]
36. Wilhite, S. E., Lumsden, R. D., and Straney, D. C. (2001) Appl. Environ. Microbiol. 67, 5055-5062[Abstract/Free Full Text]
37. Schwyn, B., and Neilands, J. B. (1987) Anal. Biochem. 160, 47-56[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eukaryot CellHome page
M. Komon-Zelazowska, T. Neuhof, R. Dieckmann, H. von Dohren, A. Herrera-Estrella, C. P. Kubicek, and I. S. Druzhinina
Formation of Atroviridin by Hypocrea atroviridis Is Conidiation Associated and Positively Regulated by Blue Light and the G Protein GNA3
Eukaryot. Cell, December 1, 2007; 6(12): 2332 - 2342.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
T. Neuhof, R. Dieckmann, I. S. Druzhinina, C. P. Kubicek, and H. von Dohren
Intact-cell MALDI-TOF mass spectrometry analysis of peptaibol formation by the genus Trichoderma/Hypocrea: can molecular phylogeny of species predict peptaibol structures?
Microbiology, October 1, 2007; 153(10): 3417 - 3437.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
D. Stack, C. Neville, and S. Doyle
Nonribosomal peptide synthesis in Aspergillus fumigatus and other fungi
Microbiology, May 1, 2007; 153(5): 1297 - 1306.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. Djonovic, M. J. Pozo, and C. M. Kenerley
Tvbgn3, a {beta}-1,6-Glucanase from the Biocontrol Fungus Trichoderma virens, Is Involved in Mycoparasitism and Control of Pythium ultimum
Appl. Envir. Microbiol., December 1, 2006; 72(12): 7661 - 7670.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
S. Zeilinger, B. Reithner, V. Scala, I. Peissl, M. Lorito, and R. L. Mach
Signal Transduction by Tga3, a Novel G Protein {alpha} Subunit of Trichoderma atroviride
Appl. Envir. Microbiol., March 1, 2005; 71(3): 1591 - 1597.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
B.-N. Lee, S. Kroken, D. Y. T. Chou, B. Robbertse, O. C. Yoder, and B. G. Turgeon
Functional Analysis of All Nonribosomal Peptide Synthetases in Cochliobolus heterostrophus Reveals a Factor, NPS6, Involved in Virulence and Resistance to Oxidative Stress
Eukaryot. Cell, March 1, 2005; 4(3): 545 - 555.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Whitmore and B. A. Wallace
The Peptaibol Database: a database for sequences and structures of naturally occurring peptaibols
Nucleic Acids Res., January 1, 2004; 32(90001): D593 - 594.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/23/20862    most recent
M201654200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wiest, A.
Right arrow Articles by Kenerley, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wiest, A.
Right arrow Articles by Kenerley, C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.